Krka DD (FRA:KN8) Total Liabilities: €689 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:KN8 Krka DD FRA:KN8
66 GF Score
Price €269.00
GF Value €148.66
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Krka DD Total Liabilities?

Krka DD FRA:KN8 +3.07% 66 Total Liabilities is €689 Mil as of Mar. 2026. GuruFocus rates FRA:KN8 with a GF Score™ of 66/100 and a GF Value™ of €148.66 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Krka DD's Total Liabilities for the quarter that ended in Mar. 2026 was €689 Mil.

Krka DD's quarterly Total Liabilities increased from Sep. 2025 (€662.58 Mil) to Dec. 2025 (€665.51 Mil) and increased from Dec. 2025 (€665.51 Mil) to Mar. 2026 (€689.41 Mil).

Krka DD's annual Total Liabilities increased from Dec. 2023 (€582.53 Mil) to Dec. 2024 (€611.24 Mil) and increased from Dec. 2024 (€611.24 Mil) to Dec. 2025 (€665.51 Mil).

Krka DD Total Liabilities Historical Data

* Premium members only.

The historical data trend for Krka DD's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krka DD Total Liabilities Chart

Krka DD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 617.90 548.99 582.53 611.24 665.51

Krka DD Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 669.64 638.02 662.58 665.51 689.41
FRA:KN8
66GF Score
Krka DD FRA:KN8
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krka DD Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Krka DD's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=500.294+(14.011+151.202
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=666

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=3042.658-2377.151
=666

Krka DD's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=523.723+(13.726+24.623
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+127.334+0)
=689

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=3170.527-2481.121
=689

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €689 Mil mean?
Krka DD (FRA:KN8) has a Total Liabilities of €689 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Krka DD and its competitors.
Is Krka DD's Total Liabilities too high?
Krka DD's current Total Liabilities is €689 Mil. Overall, Krka DD has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krka DD's Total Liabilities compare to ZTS and UTHR?
Krka DD's Total Liabilities of €689 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Krka DD and its competitors. Krka DD's current Total Liabilities is €689 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krka DD stock overvalued right now?
Based on GuruFocus' analysis, Krka DD (FRA:KN8) is currently considered Significantly Overvalued. The stock's GF Value™ is €148.66, compared to a current price of €269.00 — trading 80.9% above its estimated fair value. The current Total Liabilities is €689 Mil. Krka DD's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Krka DD (FRA:KN8), the current Total Liabilities is €689 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krka DD (FRA:KN8) Overvalued in 2026?

Based on GuruFocus' analysis, Krka DD stock appears to be overvalued. The current stock price of €269.00 is trading 80.9% above its estimated GF Value™ of €148.66. GuruFocus considers Krka DD to be Significantly Overvalued.

Key valuation signals for FRA:KN8:

  • Total Liabilities: €689 Mil
  • GF Value™: €148.66 vs. price of €269.00 (80.9% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the FRA:KN8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krka DD Business Description

Address Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
66GF Score

Get the complete analysis for FRA:KN8

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€269.00
Price
€148.66
GF Value